Long-term survival with anlotinib as a front-line treatment in an elderly NSCLC patient: A case report.

Jingyi Wang,Xiaoqing Li,Juan Zhou,Dan Qiu,Mengyao Zhang,Lan Sun,Shengwen Calvin Li

Frontiers in oncology（2023）

引用 0|浏览2

暂无评分

摘要

This patient achieved long-term survival using anlotinib as a front-line regimen combined with chemotherapy.

查看译文

关键词

Anlotinib hydrochloride,anti-angiogenesis therapy,case report,chemotherapy,elderly patients,front-line treatment,non-small cell lung cancer,tegafur-uracil

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要